President Donald Trump on Wednesday instructed administration officers to research find out how to forestall shock medical payments, broadening his deal with drug costs to incorporate different problems with worth transparency in well being care.
Flanked by sufferers and different visitors invited to the White House to share their tales of surprising and outrageous payments, Trump tasked his well being secretary, Alex Azar, and labor secretary, Alex Acosta, with engaged on an answer, a number of attendees stated.
“The pricing is hurting patients, and we’ve stopped a lot of it, but we’re going to stop all of it,” Trump said throughout a roundtable dialogue when reporters had been briefly allowed into the in any other case closed-door assembly.
David Silverstein, the founding father of a Colorado-based nonprofit known as Broken Healthcare who attended, stated Trump struck an aggressive tone, calling for an answer with “the biggest teeth you can find.”
“Reading the tea leaves, I think there’s big change coming,” Silverstein stated.
Surprise billing, or the apply of charging sufferers for care that’s dearer than anticipated or not lined by their insurance coverage, has acquired a flood of consideration up to now yr, significantly as Kaiser Health News and different information organizations have undertaken investigations into sufferers’ most outrageous medical payments.
Attendees stated every of 10 invited visitors — amongst them sufferers in addition to medical doctors with their very own tales of surprising payments — was given a possibility to speak, although Trump didn’t keep to listen to all of their tales through the roughly hourlong gathering.
The group included Paul Davis, a retired physician from Findlay, Ohio, whose household’s expertise with a $17,850 invoice for a easy urine check was detailed in a KHN-NPR “Bill of the Month” feature final yr.
Davis’ daughter, Elizabeth Moreno, was a school pupil in Texas when she had spinal surgical procedure to treatment debilitating again ache. After the surgical procedure, she was requested to supply a urine pattern and later acquired a invoice from an out-of-network lab in Houston that examined it. Experts stated such exams hardly ever value greater than $200, not almost what the lab charged Moreno and her insurance coverage firm. But fearing harm to his daughter’s credit score, Davis paid the lab $5,000 and filed a criticism with the Texas legal professional basic’s workplace, alleging “price gouging of staggering proportions.”
Davis stated White House officers made it clear that worth transparency is a “high priority” for Trump, and whereas they didn’t see eye to eye on each topic, he stated he was struck by their sincerity.
“These people seemed earnest in wanting to do something constructive to fix this,” Davis stated.
Dr. Martin Makary, a surgeon and well being coverage professional at Johns Hopkins University who has written about transparency in well being care and attended the assembly, stated it was a great alternative for the White House to listen to firsthand a few critical and widespread situation.
“This is how most of America lives, and [Americans are] getting hammered,” he stated.
Trump has usually railed towards excessive prescription drug costs however has stated much less about different issues with the nation’s well being care system. In October, shortly earlier than the midterm elections, he unveiled a proposal to tie the worth Medicare pays for some medicine to the costs paid for a similar medicine abroad, for instance.
Trump, Azar and Acosta stated efforts to manage prices in well being care had been yielding optimistic outcomes, discussing particularly the growth of affiliation well being plans and the new requirement that hospitals post their list prices online. The president additionally took credit score for the current enhance in generic drug approvals, which he stated would assist decrease drug costs.
Discussing the partial authorities shutdown, Trump stated Americans “want to see what we’re doing, like today we lowered prescription drug prices, first time in 50 years,” in line with a White House pool report.
Trump seemed to be referring to a recent claim by the White House Council of Economic Advisers that prescription drug costs fell final yr.
However, as STAT pointed out in a recent fact check, the report from which that declare was gleaned stated “growth in relative drug prices has slowed since January 2017,” not that there was an total lower in costs.
Annual will increase in total drug spending have leveled off as pharmaceutical corporations have launched fewer blockbuster medicine; patents have expired on brand-name medicine; and the waning impact of a spike pushed by the discharge of astronomically expensive drugs to treat hepatitis C. Drugmakers are additionally cautious of accelerating their costs within the midst of rising political strain.
Since Democrats seized management of the House of Representatives this month, social gathering leaders have rushed to announce investigations and schedule hearings coping with well being care, focusing particularly on drug prices and protections for these with preexisting situations.
Last week, the House Oversight Committee introduced a “sweeping” investigation into drug costs, pointing to an AARP report saying the overwhelming majority of brand-name medicine had greater than doubled in worth between 2005 and 2017.
KHN correspondents Shefali Luthra and Jay Hancock contributed to this report.
src=”http://platform.twitter.com/widgets.js” charset=”utf-8″>